New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...

The 5-year overall survival rate was 91.4% in the aspirin ... group but does not demonstrate a significant reduction in colorectal cancer recurrence over placebo, although a more modest benefit ...

28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found ... 7, 2024 — Doctors have long believed the cancer drug 5-fluorouracil works by damaging ...

The American Cancer Society recently predicted there will be around 155,000 new cases of colorectal cancer and 52,900 deaths this year ... is responsible for 3% to 5% of colon cancers.

A study revealed that probiotics combined with chemotherapy and immune checkpoint inhibitors improve survival, gut health, ...

(Photo provided by Stein) Colorectal cancer cancer grows more slowly than some other cancer and can stay in the colon or rectum for months or even years. If left untreated, it can spread to other ...

Here’s some food for thought: What’s on your plate could be putting you at risk for colorectal cancer. Once primarily ... amount,” Zaghiyan said. Last year, former US Surgeon General Vivek ...